265 related articles for article (PubMed ID: 27343748)
1. Impact of estrogen type on cardiovascular safety of combined oral contraceptives.
Dinger J; Do Minh T; Heinemann K
Contraception; 2016 Oct; 94(4):328-39. PubMed ID: 27343748
[TBL] [Abstract][Full Text] [Related]
2. Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.
Barnett C; Hagemann C; Dinger J; Do Minh T; Heinemann K
Eur J Contracept Reprod Health Care; 2017 Feb; 22(1):17-23. PubMed ID: 27749101
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
Dinger J; Möhner S; Heinemann K
Contraception; 2016 May; 93(5):378-85. PubMed ID: 26825258
[TBL] [Abstract][Full Text] [Related]
4. Unintended pregnancy rates differ according to combined oral contraceptive - results from the INAS-SCORE study.
Barnett C; Dinger J; Minh TD; Heinemann K
Eur J Contracept Reprod Health Care; 2019 Aug; 24(4):247-250. PubMed ID: 31204884
[No Abstract] [Full Text] [Related]
5. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
Dinger J; Bardenheuer K; Heinemann K
Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
[TBL] [Abstract][Full Text] [Related]
7. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
Bauerfeind A; von Stockum S; Boehnke T; Heinemann K
Obstet Gynecol; 2024 Mar; 143(3):431-434. PubMed ID: 38227942
[TBL] [Abstract][Full Text] [Related]
9. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Davis SR; Bitzer J; Giraldi A; Palacios S; Parke S; Serrani M; Mellinger U; Nappi RE
J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
Junge W; Mellinger U; Parke S; Serrani M
Clin Drug Investig; 2011; 31(8):573-584. PubMed ID: 21721593
[TBL] [Abstract][Full Text] [Related]
11. Effect of four oral contraceptives on hemostatic parameters.
Wiegratz I; Lee JH; Kutschera E; Winkler UH; Kuhl H
Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
[TBL] [Abstract][Full Text] [Related]
13. Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
Kangasniemi MH; Arffman RK; Haverinen A; Luiro K; Hustad S; Heikinheimo O; Tapanainen JS; Piltonen TT
Contraception; 2022 Dec; 116():59-65. PubMed ID: 36084710
[TBL] [Abstract][Full Text] [Related]
14. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
[TBL] [Abstract][Full Text] [Related]
15. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database.
Li J; Panucci G; Moeny D; Liu W; Maro JC; Toh S; Huang TY
JAMA Intern Med; 2018 Nov; 178(11):1482-1488. PubMed ID: 30285041
[TBL] [Abstract][Full Text] [Related]
16. Estradiol valerate/dienogest: a novel combined oral contraceptive.
Borgelt LM; Martell CW
Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
[TBL] [Abstract][Full Text] [Related]
17. Effect of dienogest-containing oral contraceptives on lipid metabolism.
Wiegratz I; Lee JH; Kutschera E; Bauer HH; von Hayn C; Moore C; Mellinger U; Winkler UH; Gross W; Kuhl H
Contraception; 2002 Mar; 65(3):223-9. PubMed ID: 11929644
[TBL] [Abstract][Full Text] [Related]
18. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
Kangasniemi MH; Arffman RK; Joenväärä S; Haverinen A; Luiro K; Tohmola T; Renkonen R; Heikinheimo O; Tapanainen JS; Piltonen TT
Hum Reprod; 2023 Jan; 38(1):89-102. PubMed ID: 36416543
[TBL] [Abstract][Full Text] [Related]
19. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
Fraser IS; Jensen J; Schaefers M; Mellinger U; Parke S; Serrani M
Contraception; 2012 Aug; 86(2):96-101. PubMed ID: 22240178
[TBL] [Abstract][Full Text] [Related]
20. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
Haverinen AH; Luiro KM; Szanto T; Kangasniemi MH; Hiltunen L; Sainio S; Piltonen TT; Lassila R; Tapanainen JS; Heikinheimo O
Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1102-1111. PubMed ID: 35909329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
